Navigation Links
PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients
Date:10/24/2008

al trials that evaluate long-term clinical benefit for CF patients."

Patients with CF lack adequate levels of the CFTR protein, a chloride channel which is required for normal function of the lung, pancreas, liver and other organs. Nonsense mutations are single-point alterations in the genetic code that when transcribed into mRNA prematurely stop the mRNA translation process, preventing production of a full-length, functional protein. Patients with nonsense-mutation CF make virtually no CFTR protein and thus often have a more severe form of CF. Nonsense mutations are responsible for approximately 10 percent of the cases of CF worldwide.

By inducing the production of functional CFTR, PTC124 addresses one of the underlying genetic defects responsible for CF. Earlier studies of PTC124 in adults with CF evaluated nasal transepithelial potential difference (TEPD) as a surrogate for the presence and activity of the CFTR protein. Across a variety of studies, TEPD assessments showed statistically significant improvements of mean CFTR-dependent chloride secretion in the airways.

European Phase 2a Study Results

The multicenter, randomized, open-label Phase 2a study demonstrated that treatment with PTC124 caused improvements in CFTR-mediated chloride conductance and in apical expression of CFTR protein in nasal epithelium. The study enrolled 30 children ages 6 to 18 years to evaluate the activity, safety and pharmacokinetic activity of PTC124 in pediatric patients. All of the patients had nonsense-mutation CF, pathological lung infection, and CF-induced pancreatic insufficiency. In a cross-over design testing 14 days of PTC124 at two dose levels, patients were randomized to receive either the lower or higher dose first. PTC124 treatment across both dose levels was associated with a statistically significant (p=0.03) increase in the proportion of epithelial cells showing cell surface CFTR protein. PTC124 also induced significantly improved CFTR-media
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
3. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
4. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
5. Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
6. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
7. Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
8. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
9. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
10. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
11. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Thoratec Corporation (NASDAQ: ... support therapies to save, support and restore failing hearts, ... Morgan Stanley Global Healthcare Conference on Wednesday, September 10. ... Chief Executive Officer, will provide an update on the ... a.m., Pacific Daylight Time).   A webcast ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "China Orthopedic Instrument Industry Report, 2014-2017" ... accelerated aging population and rising proportion of reimbursement for ... been effectively released, with its scale presenting a CAGR ... joint products are three product segments of orthopedic instruments ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets  has ... Pipeline Insight 2014" report to their offering. ... is one of the largest segments of pharmaceuticals industry. The ... while the available therapies were unable to meet the market ... market for CNS disorder, especially over the past two decades. ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2US CNS Disorders Drug Pipeline Insight 2014 2
(Date:8/30/2014)... Franklin, TN (PRWEB) August 30, 2014 ... techniques, including nine mobilizations and six muscle energy techniques. ... also narrates and demonstrates twenty-seven examination techniques for the ... course supports Dr. Reiman's live course presentation with ... Objectives, Applying a differential diagnosis ...
(Date:8/30/2014)... 2014 The KSF (Kung Fu Sanshou ... Search on November 8th, 2014 at the Mobile Civic ... have introduced many notorious and notable fighters for some ... the UFC. , Among these KSF along with ... doors armed with the virtues of true indomitable Shaolin ...
(Date:8/30/2014)... 30 August 2014: The first multidisciplinary recommendations on ... coronary syndromes (ACS) are published today in ... written jointly by the European Heart Rhythm Association ... the European Association of Percutaneous Cardiovascular Interventions (EAPCI), ... Gorenek (Turkey), chairperson of the task force, said: ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: The first ... anticoagulants in pulmonary embolism are published today in ... ESC Congress by Professor Stavros V. Konstantinides (Germany/Greece) ... ESC Guidelines on the diagnosis and management of ... European Heart Journal (1) and on the ESC ...
(Date:8/29/2014)... Daily Gossip writes in its review that this ... nowadays. This method promises to teach readers how to eliminate ... effective alternative sources for the production of energy. , ... and solar power. , The Home Made Energy review ... eBook. So, this is an online guide that will teach ...
Breaking Medicine News(10 mins):Health News:North American Seminars Online PT Continuing Education Course, Examination and Treatment of the SI Joint, Receives Continuing Education Approval in NJ, CA, IL, PA, & TX 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 3Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 4Health News:First multidisciplinary recommendations on management of arrhythmias in ACS patients 2Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Home Made Energy Review Exposes Simple Method to Access Alternative Energy Sources 2
... and improves ... customer ... subsidiary of Hays plc., one of the world,s leading specialist,recruitment ... processes and improve customer service., Hays stated that it ...
... in the United States, WARSAW, Ind., Jan. ... SWX: ZMH), a leader in the orthopaedic industry, ... have been completed in,the United States. The Zimmer ... the rigid stabilization of the OPTIMA(TM) ZS,Spinal System ...
... WILMINGTON, Del., Jan. 8 DuPont (NYSE: ... Environmental Protection,Agency for Agility(TM) SG herbicide, a new ... tool for broad spectrum weed control, including,ALS resistant ... modes of action in a single formulation to ...
... could add 14 years, study says , , TUESDAY, ... lifestyle behaviors -- not smoking, physical activity, moderate alcohol ... a day -- live an average of 14 years ... new British study contends. , Researchers at the University ...
... millions of Americans are having to dig deeper into their own ... , The reason" Higher co-payments that took effect January 1, as ... by making employees and retirees pay more. , But a ... down at least for some people taking some drugs. , ...
... Jan. 7 Digirad Corporation,(Nasdaq: DRAD ), ... services to physicians, offices, hospitals and imaging centers, ... R. King Nelson, a,director and member of the ... today., Nelson, 50, has served on Digirad,s ...
Cached Medicine News:Health News:Hays AG Integrates Authentidate(R) Signature Solution for Electronic Invoicing 2Health News:Hays AG Integrates Authentidate(R) Signature Solution for Electronic Invoicing 3Health News:Hays AG Integrates Authentidate(R) Signature Solution for Electronic Invoicing 4Health News:Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System 2Health News:Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System 3Health News:Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System 4Health News:New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs 2Health News:Small Lifestyle Changes Can Boost Longevity 2Health News:Study proves the co-pay connection in chronic disease 2Health News:Study proves the co-pay connection in chronic disease 3Health News:Study proves the co-pay connection in chronic disease 4Health News:Digirad Corporation Board of Directors Appoints R. King Nelson Chairman 2Health News:Digirad Corporation Board of Directors Appoints R. King Nelson Chairman 3Health News:Digirad Corporation Board of Directors Appoints R. King Nelson Chairman 4
Digital Imaging for Optical Screening:,Diabetes, Glaucoma Macular Degeneration, and other retinal disease....
... Laboratory is a comprehensive, ... manages specimen data from ... tracking to final cumulative ... is a multi-module system ...
... optimal speed, efficiency and results, without the ... Most importantly, EZLink meets strategic laboratory network ... in the same facility - without sacrificing ... paperless laboratory, the network can be linked ...
... Windows NT client server system that combines ... power and high-speed volume required to meet ... industry experts, LabNet is structured to make ... and effective as possible. Our system can ...
Medicine Products: